Do-Hyun Nam

This inventor holds 12 USPTO granted patents and 11 published patent applications, plus 7 CIPO patents and 6 EPO patents. Top assignees: Samsung Life Public Welfare Foundation, Aimed Bio Inc., Sejong University. Active years: 2008-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Do-Hyun Nam. Retrieved from https://idiyas.com/inventor/do-hyun-nam-2t8i0hey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 11)

% Patents Active = 83.3

CIPO Patents = 7 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 13)

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 12(Granted Patents)

Location History:

Taejeon, KR (2008)
Seoul, KR (2015 - 2024)

Company Filing History:

6 out of 145

Samsung Life Public Welfare Foundation

Daegu-Gyeongbuk Medical Innovation Foundation

patents

5. 1 out of 75

Lg Life Sciences, Limited

patents

6. 1 out of 264

National Cancer Center

patents

where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11938115 - Benzoselenophene-based compound, pharmaceutical composition containing same, and antibody-drug conjugate (2024-03-26),

2. 11591718 - Magnetic-based biopanning method through attachment of magnetic bead to cell (2023-02-28),

3. 11576896 - Benzoselenophene-based compounds, pharmaceutical compositions and antibody-drug conjugates including the same (2023-02-14),

4. 11208412 - Pyrrolo-pyrimidine derivative compound, preparation method therefor, and pharmaceutical composition comprising same compound as effective ingredient for preventing or treating protein kinase-related disease (2021-12-28),

5. 11199536 - Method for screening antibody using patient-derived tumor spheroids (2021-12-14),

6. 11085930 - Anti-NRP1 antibody screening method (2021-08-10),

7. 10669340 - Antibody against EGFRvIII and use thereof (2020-06-02),

8. 10364289 - Antibody binding to neuropilin 1 and use thereof (2019-07-30),

9. 9365590 - Selenophene-fused aromatic compound and manufacturing method thereof (2016-06-14),

10. 9296817 - Antibodies cross-reactive to human and mouse c-Met and uses thereof (2016-03-29),

11. 9133156 - Method for preparing selenyl-substituted aromatic aldehyde compounds (2015-09-15),

12. 7361762 - Process for preparing acid salts of Gemifloxacin (2008-04-22),

Title: Inventor Do-Hyun Nam

Introduction: Do-Hyun Nam is a renowned inventor based in Seoul, South Korea, known for his groundbreaking innovations in various fields.

Latest Patents: Do-Hyun Nam holds several patents in the areas of technology and healthcare, showcasing his diverse range of expertise and creativity.

Career Highlights: Throughout his career, Do-Hyun Nam has consistently pushed the boundaries of innovation, with his inventions making a significant impact on society. His dedication to research and development has led to the creation of cutting-edge solutions that have improved the lives of many.

Collaborations: Do-Hyun Nam has collaborated with leading companies and research institutions both locally and internationally, further expanding the reach and influence of his inventions. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Do-Hyun Nam's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.